Menu

Know Labs, Inc. (KNW)

$2.14
+0.00 (0.00%)

Data provided by IEX. Delayed 15 minutes.

Market Cap

$16.1M

P/E Ratio

N/A

Div Yield

0.00%

52W Range

$0.40 - $4.43

Company Profile

At a glance

Know Labs (NYSE American: KNW) is developing proprietary non-invasive diagnostic technology utilizing radio and microwave spectroscopy, with a primary focus on a continuous blood glucose monitor (CGM) and a secondary strategy to license its extensive IP portfolio in other fields.

Recent operational progress includes the development of the wearable KnowU (Generation 2) prototype, achieving promising early clinical study results with MARD figures around 11% compared to venous blood, and significantly expanding its global patent portfolio (>300 assets).

The company faces significant financial challenges, including recurring losses, a net working capital deficit of $6.19 million as of March 31, 2025, and cash sufficient to operate only until June 30, 2025, raising substantial doubt about its ability to continue as a going concern.

Price Chart

Loading chart...

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks